Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Atypical Antipsychotics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103724294A reveals a novel route for Quetiapine intermediates, eliminating high-temperature distillation to ensure superior purity and supply chain stability.
Advanced synthesis of Quetiapine Hemifumarate via novel thiosalicylic acid route. High yield, eco-friendly process for cost-effective API manufacturing.